CEOInterviews.AI
Verified executive transcripts, quotes, and interview insights from Opus Genetics leadership.
Clinical-stage ophthalmic gene therapy company for inherited retinal diseases (site reports 2026 OPGx-BEST1 data). [BIOTECH-2026-10-04]
Search transcripts, quotes, and verified statements from every Opus Genetics executive via our platform or API.